EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, BMXXY: Biomerieux S A Unsp/Adr

02 Oct 2026
LAST:

9.041

CHANGE:
 0.08		OPEN:
9.041		HIGH:
9.041		ASK:
0.000		VOLUME:
400
CHG(%):
0.87		PREV:
9.120		LOW:
9.041		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Oct 269.0419.0419.0419.041400
01 Oct 269.1209.1209.1209.120300
30 Sep 269.2409.2509.2409.240500
29 Sep 269.2619.3908.8909.390700
28 Sep 269.5109.5309.4559.5301.5K
25 Sep 269.3309.3309.3309.330500
24 Sep 269.1659.2508.8359.2502.2K
23 Sep 268.8588.9708.8588.9701.1K
22 Sep 268.6988.8508.3758.8501.3K
21 Sep 268.6558.7508.6558.750600

PROFILE

Name:Biomerieux S A Unsp/Adr
About:bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemase producing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO or 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDAS, a specific marker of severe bacterial infections/sepsis. It also develops Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. It has partnership with Boehringer Ingelheim and Evotec. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Sector:Healthcare
Address:376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280
Website:https://www.biomerieux.com
FIGI:BBG00B0SGTH4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:39.51 
Forward P/E:25.97 
Price to Sales:4.19 
Price to Book:3.74 
DivYield:0.06 
Div/Share:0.90 
Revenue:4.122B 
EBITDA:999.5M 
Shares:1.181B 
Market Cap:10.674B 

TECHNICAL INDICATORS

MA5:9.262.5%
MA10:9.151.2%
MA20:8.862.1%
MA50:8.496.5%
MA100:9.201.7%
STO9:28.09
STO14:58.56
RSI14:53.90
WPR14:-41.44
MTM14:0.50
ROC14:0.06 
ATR:0.25 
Week High:9.535.4%
Week Low:8.891.7%
Month High:9.535.4%
Month Low:7.85
Volatility:67.78